Country Profile at a Glance

Market Overview

Healthcare Infrastructure

Portugal operates a National Health Service (SNS — Serviço Nacional de Saúde) providing near-universal coverage, alongside a significant private health sector growing at 8% annually. The SNS manages approximately 100 public hospitals and over 2,000 health centres. Major private hospital groups — Luz Saúde, José de Mello Saúde, and HPA Health Group — are expanding and actively sourcing international medical equipment. Central procurement for the public sector is coordinated through SPMS (Serviços Partilhados do Ministério da Saúde), which runs framework agreements for hospital supplies.

Key Market Drivers

• EU membership — CE-marked products require no additional national registration to enter the market
• SNS hospital modernisation programme investing EUR 4 billion through 2030
• Rapidly growing private hospital sector actively sourcing quality EU-certified equipment
• Aging population (23% over 65) driving sustained demand for geriatric, cardiovascular, and oncology devices
• Portugal as linguistic bridge to Brazilian, Angolan, and Mozambican markets via Portuguese-speaking distributors
• Growing medical tourism (cosmetic, dental, orthopaedic) driving private clinic investment

Top Product Categories in Demand

Regulatory Environment

Framework & Authority

As an EU member state, Portugal applies EU MDR (2017/745) directly — no separate national registration is required beyond CE marking. The national competent authority is Infarmed (Autoridade Nacional do Medicamento e Produtos de Saúde, I.P.), which oversees market surveillance and vigilance reporting. Portuguese-language labelling and Instructions for Use are required for devices sold in Portugal. The SPMS framework agreement system is the primary procurement route for public hospitals.

Key Registration Requirements

• CE marking under EU MDR — no additional Portuguese national registration required
• Portuguese-language labelling and IFU mandatory
• EUDAMED actor registration and UDI submission required
• EU Authorised Representative required for Turkish (non-EU) manufacturers
• Infarmed notification for certain device categories (Class III and implantables)
• Public procurement: SPMS framework agreement or direct tender participation

Import & Trade Data

Portugal imports approximately 80% of its medical devices. The dominant suppliers are Germany, USA, France, Spain, and the Netherlands. Turkey's current export share is growing — approximately 2% — primarily in disposables, hospital furniture, and basic surgical instruments. Portugal's openness to competitive EU-quality suppliers and its relatively lower level of established supplier lock-in compared to Germany or France makes it an accessible entry point.

Opportunities for Turkish Exporters

• Zero-tariff EU market access: CE-marked Turkish products enter Portugal with no import duty — a direct 0% cost advantage vs non-EU competitors
• SPMS framework agreements: winning a place on Portugal's national public procurement frameworks creates multi-year, multi-hospital volume opportunities across the SNS
• Portuguese-speaking distributor network: a Lisbon-based distributor often has sister companies or partners in Brazil, Angola, and Mozambique — creating multi-continent distribution from a single relationship
• Private hospital group procurement: Luz Saúde and José de Mello Saúde are actively modernising facilities and seeking quality alternatives to dominant European brands
• Dental market: Portugal has a very active private dental sector with high per-capita implant and equipment consumption

Challenges & Considerations

• SPMS public tender cycles: public hospital procurement is centralised and runs on multi-year cycles — timing market entry to tender windows is important
• Language requirement: Portuguese-language labelling and documentation are mandatory; professional translation is required for all regulated materials
• Price competition from Spain: Spanish medical device distributors have strong natural advantages in Portugal through cultural and geographic proximity
• Payment cycles in public sector: SNS hospitals can have 60–90 day payment cycles; distributor cash flow planning is important

Conclusion

Portugal offers Turkish medical device exporters a rare combination: a fully EU-regulated market with zero tariff access, a growing private sector, and a linguistic gateway to four continents of Portuguese-speaking markets. For Turkish manufacturers already CE-marked and seeking their first EU market entry, Portugal's accessible procurement culture and active search for quality alternatives makes it an ideal starting point.